WFS1
WFS1 (wolframin ER transmembrane glycoprotein, also known as wolframin, DIDMOAD, WFS, DFNA6, DFNA14 and DFNA38) is an endoplasmic reticulum membrane protein that helps regulate cellular calcium homeostasis and the ER stress response. Mutations in the WFS1 gene cause Wolfram syndrome. Browse Assay Genie's current range of WFS1 research reagents below, or read on for the biology behind the target.
WFS1 participates in the regulation of cellular Ca(2+) homeostasis, at least in part by modulating the filling state of the endoplasmic reticulum Ca(2+) store. It also acts as a negative regulator of the ER stress response. In addition, WFS1 positively regulates the stability of the V-ATPase subunits ATP6V1A and ATP1B1, preventing their degradation through a proteasome-independent mechanism that remains unknown.
The WFS1 gene encodes a transmembrane protein, wolframin, that is located primarily in the endoplasmic reticulum. UniProt also records it in cytoplasmic secretory vesicles. According to the NCBI Gene summary, it is ubiquitously expressed, with the highest levels in brain, pancreas, heart and insulinoma beta-cell lines. Alternatively spliced transcript variants have been described for the gene. The mouse ortholog is Wfs1, which is useful for researchers working in rodent models.
Mutations in the WFS1 gene are associated with Wolfram syndrome, also called DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy and deafness). This is an autosomal recessive disorder that affects the brain and central nervous system. The gene's earlier name, Wolfram syndrome 1 (wolframin), reflects this link. Mutations can also cause autosomal dominant deafness 6 (DFNA6), also known as DFNA14 or DFNA38, which accounts for several of the aliases used in the literature.
WFS1 mutations are associated with Wolfram syndrome (DIDMOAD), a recessive disorder affecting the brain and central nervous system.
WFS1 negatively regulates the ER stress response, making it a relevant target for studying how cells handle ER stress.
WFS1 modulates the filling state of the ER Ca(2+) store, contributing to cellular calcium homeostasis.
Mutations in WFS1 can cause autosomal dominant deafness 6 (DFNA6, DFNA14, DFNA38), linking the gene to inherited hearing loss.
WFS1 participates in cellular Ca(2+) homeostasis, at least partly by modulating the filling state of the ER Ca(2+) store. It negatively regulates the ER stress response and supports the stability of V-ATPase subunits ATP6V1A and ATP1B1 by preventing their degradation through an unknown proteasome-independent mechanism.
WFS1 is also called wolframin, and its previous name was Wolfram syndrome 1 (wolframin). Aliases include DIDMOAD, WFS, DFNA6, DFNA14 and DFNA38. DIDMOAD stands for diabetes insipidus, diabetes mellitus, optic atrophy and deafness. Alternatively spliced transcript variants have been reported.
Yes. WFS1 mutations are associated with autosomal recessive Wolfram syndrome and can also cause autosomal dominant deafness 6 (DFNA6/DFNA14/DFNA38). The mouse ortholog is Wfs1. Check the datasheet of any product for its validated reactivity.
V-ATPase and ATPase subunits stabilised by WFS1, with other ER stress and calcium homeostasis targets.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O76024; product specifications from Assay Genie datasheets.